Cutaneous manifestations of end-stage renal disease

Journal of the American Academy of Dermatology

Volumn 43, Issue 6, 2000, Pages 975-986

  Robinson Bostom, Leslie ^a   DiGiovanna, John J ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BULLOUS SKIN DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; PRURITUS; REVIEW; SKIN CALCIFICATION; SKIN MANIFESTATION;

EID: 0033674175     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2000.110651     Document Type: Article

References (67)

1. Uremic toxins: What are they? How are they identified?
2. The 'half and half nail' of uremic onychopathy
3. Pruritus in end stage renal disease
4. Uremic pruritus
5. Cutaneous abnormalities in uremic patients
6. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD): The role of plasma histamine and skin mast cells
7. Pruritus in patients on maintenance hemodialysis
8. Clinical features of pruritus among patients undergoing maintenance hemodialysis
9. Clinical and histological skin changes in chronic renal failure: Evidence for a dialysis-resistant transplant-responsive microangiopathy
10. Pruritus and skin hydration during dialysis
11. Relationship between pruritus, transepidermal water loss, and biochemical markers of renal itch in haemodialysis patients
12. Uremic pruritus: A review
13. Disappearance of uremic itching after subtotal parathyroidectomy
14. Plasma histamine in patients with chronic renal failure and nephrotic syndrome
15. Magnesium studies in hemodialysis patients before and after treatment with low dialysate magnesium
16. Dermal mast cell density and pruritus in end stage renal failure
17. Intraepidermal neuron specific endolase (NSE)-immunoreactive nerve fibers: Evidence for sprouting in uremic patients on maintenance hemodialysis
18. Relief from uremic pruritus: A therapeutic approach
19. Ultraviolet phototherapy of uremic pruritus: Long-term results and possible mechanism of action
20. Uremic pruritus treated with ultraviolet light
21. Relief of uremic pruritus with ultraviolet phototherapy
22. Treatment of uremic pruritus with blue light
23. Oral activated charcoal in patients with uremic pruritus
24. Randomized crossover trial of naltrexone in uraemic pruritus
25. Naltrexone does not relieve uremic pruritus: Results of a randomized double blind, placebo-controlled crossover study
26. Dialysis pruritus: Effect of cimetidine
27. Cholestyramine in uraemic pruritus
28. Pruritus in dialysis patients treated with parenteral lidocaine
29. Identifying effective treatments for uremic pruritus
30. Thalidomide for the treatment of uremic pruritus: A crossover randomized double-blind trial
31. Electric needle therapy of uremic pruritus
32. Reactive perforating collagenosis associated with diabetes mellitus
33. Acquired perforating disease associated with chronic renal failure
34. Acquired perforating disease: Report of nine cases
35. The perforating disorders
36. Acquired perforating dermatosis in a British dialysis population
37. Kyrle's disease in patients with chronic renal failure
38. Perforating folliculitis is associated with hemodialysis
39. The evolution of perforating folliculitis in patients with chronic renal failure
40. Acquired perforating dermatosis
41. Calcifying disorders of the skin
42. Five cases of calciphylaxis and a review of the literature
43. Calciphylaxis: A syndrome of skin necrosis and acral gangrene in chronic renal failure
44. The vascular calcification-cutaneous necrosis syndrome
45. Uremic small artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): A complication of chronic renal failure and benefit from parathyroidectomy
46. Cutaneous necrosis from calcific uremic arteriolopathy
47. Systemic calciphylaxis revisited
48. Calciphylaxis and systemic calcinosis: Collective review
49. A case control study of proximal calciphylaxis
50. Mathematical formulation to help identify the patient at risk of ischemic tissue necrosis: A potentially lethal complication of chronic renal failure
51. Calciphylaxis in chronic renal failure
52. Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis
53. The vascular lesions associated with skin necrosis in renal disease
54. Calcifying panniculitis with renal failure: A new management approach
55. Calciphylaxis: A favorable outcome with hyperbaric oxygen
56. Hyperbaric oxygen in calciphylaxis-induced necrosis in a peritoneal dialysis patient
57. Bullous dermatosis of end stage renal disease and aluminum
58. Removal of plasma porphyrins with high flux hemodialysis in porphyria cutanea tarda associated with end stage renal disease
59. Successful treatment of hemodialysis-related porphyria cutanea tarda with deferoxamine
60. Bullous dermatosis of end stage renal disease: A possible association between abnormal porphyrin metabolism and aluminum
61. Haemodialysis-related porphyria cutanea tarda and treatment by recombinant human erythropoietin
62. Porphyria cutanea tarda-like aspects in two prolonged hemodialysis patients
63. Bullous dermatosis of hemodialysis